Hae Yun Nam
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 4
- Pharmaceutical Science top 1%
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 8
- Epigenetics and DNA Methylation 4
- Advanced biosensing and bioanalysis techniques 4
- Molecular Medicine top 10%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
-
- Autophagy in Disease and Therapy 9
-
- Cancer-related Molecular Pathways 7
-
- Nanoplatforms for cancer theranostics 5
Hae Yun Nam
31 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 116
- Biomaterials 835
- Pharmaceutical Science 272
- Molecular Biology 1.1k
- Molecular Medicine 70
- Cancer Research 212
Countries citing papers authored by Hae Yun Nam
This map shows the geographic impact of Hae Yun Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hae Yun Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hae Yun Nam more than expected).
Fields of papers citing papers by Hae Yun Nam
This network shows the impact of papers produced by Hae Yun Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hae Yun Nam. The network helps show where Hae Yun Nam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hae Yun Nam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2021 | 33 | |
| 4 | 2020 | 13 | |
| 5 | 2019 | 40 | |
| 6 | 2019 | 5 | |
| 7 | 2015 | 87 | |
| 8 | 2015 | 87 | |
| 9 | Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation. | 2014 | 41 |
| 10 | 2014 | 22 | |
| 11 | 2013 | 53 | |
| 12 | 2013 | 45 | |
| 13 | 2012 | 3 | |
| 14 | 2012 | 53 | |
| 15 | 2011 | 25 | |
| 16 | 2009 | 488 | |
| 17 | 2009 | 28 | |
| 18 | 2008 | 177 | |
| 19 | 2007 | 51 | |
| 20 | 2006 | 24 |
About Hae Yun Nam
Hae Yun Nam is a scholar working on Cancer Research, Geriatrics and Gerontology and Genetics, having authored 32 papers that have together received 2.2k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (9 papers), RNA Interference and Gene Delivery (8 papers), Cancer-related Molecular Pathways (7 papers), Nanoplatforms for cancer theranostics (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Biomaterials (835 citations), Pharmaceutical Science (272 citations) and Molecular Biology (1.1k citations). Hae Yun Nam has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Ick Chan Kwon, Kwangmeyung Kim, Jae Hyung Park, Kyeongsoon Park, Seo Young Jeong, Seong Who Kim, Seulki Lee, Kuiwon Choi, Hyesung Jeon and Sang Yoon Kim. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.